Variables | Univariate simple regression analysis among 75% of the daughters (n = 482) | Multivariate backward regression analysis among 75% of the daughters (n = 452) | Multivariate backward regression analysis among 25% of the daughters (n = 147) | |||
---|---|---|---|---|---|---|
Mean (standard deviation) or percentage | Association1 | Beta (standard error) | Standardized Beta | Beta (standard error) | Standardized Beta | |
HPV vaccination uptake | Â | .35** | 0.36 (0.14) | .09* | 0.92 (0.25) | .23** |
Has not received three HPV-injections (reference) | 52 | Â | Â | Â | Â | Â |
Has received three HPV-injections | 48 | Â | Â | Â | Â | Â |
Sample | Â | .00 | 0.15 (0.13) | .04 | 0.11 (0.23) | .03 |
Praeventis (reference) | 64 | Â | Â | Â | Â | Â |
Online panel | 36 | Â | Â | Â | Â | Â |
Socio-demographic variables | Â | Â | Â | Â | Â | Â |
Age | 13.51 (0.51) | .00 | Â | Â | Â | Â |
Educational level daughter | Â | .00 | Â | Â | Â | Â |
Low (reference) | 59% | Â | Â | Â | Â | Â |
Intermediate | 41% |  | 0.22 (0.12) | .06 | −0.11 (0.21) | -.03 |
Highest completed level of education of parents | Â | .00 | Â | Â | Â | Â |
Low (reference) | 22% | Â | Â | Â | Â | Â |
Intermediate | 32% | Â | 0.08 (0.15) | .02 | 0.18 (0.24) | .04 |
High | 46% | Â | 0.04 (0.15) | .01 | 0.31 (0.23) | .08 |
Country of birth mother | Â | .00 | Â | Â | Â | Â |
The Netherlands (reference) | 74% | Â | Â | Â | Â | Â |
Surinam/Antilles | 7% | Â | 0.05 (0.24) | .01 | 0.08 (0.41) | .01 |
Turkey/Morocco | 15% |  | −0.09 (0.19) | -.02 | 0.25 (0.34) | .04 |
Other | 4% |  | 0.08 (0.26) | .01 | −1.18 (0.45) | -.13 |
Country of birth daughter | Â | .00 | Â | Â | Â | Â |
The Netherlands (reference) | 92% | Â | Â | Â | Â | Â |
Surinam/Antilles | 2% |  | −0.74 (0.43) | -.05 | −0.03 (0.59) | −0.00 |
Turkey/Morocco | 3% | Â | 0.21 (0.33) | .02 | - | - |
Other | 3% | Â | 0.35 (0.33) | .03 | 1.62 (0.56) | .13* |
Protestant religion | Â | .02* | Â | Â | Â | Â |
No (reference) | 82% | Â | Â | Â | Â | Â |
Yes | 19% |  | 0.02 (0.13) | .00 | −0.15 (0.23) | -.03 |
Social psychological variables | Â | Â | Â | Â | Â | Â |
Knowledge about the HPV vaccination | 3.59 (2.41) | .00 | Â | Â | Â | Â |
Risk perception (having received no HPV vaccination) | −0.61 (1.39) | .23** | 0.19 (0.04) | .13** |  |  |
Risk perception (having received the HPV vaccination) | −1.49 (1.22) | .00 |  |  |  |  |
Attitude towards the HPV vaccination | 2.43 (6.02) | .62** | 0.12 (0.01) | .37** | 0.14 (0.03) | .39** |
Negative outcome expectations of the HPV vaccination | 5.66 (4.71) | .09** | Â | Â | Â | Â |
Positive outcome expectations of the HPV vaccination | −1.02 (4.17) | .10** |  |  |  |  |
Anticipated regret about rejecting the HPV vaccination | 3.24 (1.43) | .27** | Â | Â | 0.24 (0.08) | .17* |
Anticipated regret about receiving the vaccination | 3.11 (1.52) | .09** | Â | Â | Â | Â |
Beliefs about the HPV vaccination | 2.11 (8.31) | .47** | 0.05 (0.01) | .21** | Â | Â |
Relative effectiveness of the HPV vaccination | −2.45 (2.61) | .36** |  |  |  |  |
Ambivalence towards the HPV vaccination decision | −0.11 (4.64) | .00 |  |  |  |  |
Confidence in authorities involved in the HPV vaccination | 1.46 (3.49) | .29** | Â | Â | Â | Â |
Subjective norms towards the HPV vaccination | 13.87 (18.60) | .46** | 0.02 (0.00) | .15** | 0.03 (0.01) | .23* |
Descriptive norms towards the HPV vaccination | 4.51 (1.42) | .11** | Â | Â | Â | Â |
Self-efficacy expectations towards the HPV vaccination | 1.43 (4.70) | .06** | Â | Â | Â | Â |
HPV vaccination information processing | 1.00 (3.16) | .03** | Â | Â | Â | Â |
Habit strength towards the HPV vaccination | −0.28 (3.02) | .32** | 0.08 (0.02) | .12** |  |  |
Decisional conflict about the HPV vaccination – value clarity | 1.92 (3.99) | .02* |  |  |  |  |
Decisional conflict about the HPV vaccination – certainty | 2.06 (4.12) | .01 |  |  |  |  |
Opinion about alternative medicine | −0.28 (1.65) | .00 |  |  |  |  |
Past experience of the mother with cervical cancer | Â | .00 | Â | Â | Â | Â |
No (reference) | 98% | Â | Â | Â | Â | Â |
Yes | 2% | Â | Â | Â | Â | Â |
Past experience of the mother with other cancer forms | Â | .00 | Â | Â | Â | Â |
No (reference) | 96% | Â | Â | Â | Â | Â |
Yes | 4% | Â | Â | Â | Â | Â |
Past experience of the mother with abnormal pap smear | Â | .00 | Â | Â | Â | Â |
No (reference) | 92% | Â | Â | Â | Â | Â |
Yes | 8% | Â | Â | Â | Â | Â |
Past experience of someone from the close environment with cervical cancer | Â | .00 | Â | Â | Â | Â |
No (reference) | 87% | Â | Â | Â | Â | Â |
Yes | 13% | Â | Â | Â | Â | Â |
Past experience of someone from the close environment with other cancer forms | Â | .00 | Â | Â | Â | Â |
No (reference) | 22% | Â | Â | Â | Â | Â |
Yes | 78% | Â | Â | Â | Â | Â |
Past experience of someone from the close environment with abnormal pap smear | Â | .01 | Â | Â | Â | Â |
No (reference) | 86% | Â | Â | Â | Â | Â |
Yes | 14% | Â | Â | Â | Â | Â |
Model fit for multivariate models | Â | Â | Â | Â | Â | Â |
R2 of HPV vaccination uptake | Â | Â | Â | .36 | Â | .49 |
R2 change of HPV vaccination uptake | Â | Â | Â | .36 | Â | .49 |
F change of HPV vaccination uptake | Â | Â | Â | 257.28** | Â | 137.34** |
R2 of HPV vaccination uptake + sample | Â | Â | Â | .36 | Â | .49 |
R2 change of HPV vaccination uptake + sample | Â | Â | Â | .00 | Â | .00 |
F change of HPV vaccination uptake + sample | Â | Â | Â | 0.16 | Â | 0.58 |
R2 of HPV vaccination uptake + sample + socio-demographic variables | Â | Â | Â | .38 | Â | .54 |
R2 change of HPV vaccination uptake + sample + socio-demographic variables | Â | Â | Â | .02 | Â | .05 |
F change of HPV vaccination uptake + sample + socio-demographic variables | Â | Â | Â | 1.41 | Â | 1.54 |
R2 of HPV vaccination uptake + sample + socio-demographic + social-psychological variables | Â | Â | Â | .73 | Â | .77 |
R2 change of HPV vaccination uptake + sample + socio-demographic + social-psychological variables | Â | Â | Â | .34 | Â | .24 |
F change of HPV vaccination uptake + sample + socio-demographic + social-psychological variables | Â | Â | Â | 109.17** | Â | 45.91** |